id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-P-0401-0004,FDA,FDA-2004-P-0401,Memorandum between FDA/DMB and FDA/CDER,Other,Memorandum,2013-10-01T04:00:00Z,2013,10,2013-10-01T04:00:00Z,,2025-03-27T21:33:51Z,,0,0,09000064814413c3
FDA-2004-P-0401-0003,FDA,FDA-2004-P-0401,"Letter from FDA/CDER to Foley & Lardner, L.L.P.",Other,Letter(s),2005-06-29T04:00:00Z,2005,6,2005-06-24T04:00:00Z,,2025-03-27T21:38:30Z,,0,0,09000064804744da
FDA-2004-P-0401-0001,FDA,FDA-2004-P-0401,"Acknowledgment Letter from FDA/CDER to Andrx Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-29T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-28T01:00:45Z,,0,0,09000064804744d0
FDA-2004-P-0401-0002,FDA,FDA-2004-P-0401,"Acknowledgment Letter from FDA/CDER to Andrx Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-29T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-27T21:26:48Z,,0,0,09000064804744d6